PT
Protagenic Therapeutics, Inc.
PTIX · OTC
$0.86 -6.47% (-$0.06)
1M -21.56%
Market Cap $1.55M
P/E Ratio 0.28x
Div. Yield -
ROE -
Bulios Fair Price
$1.22
42.7% upside
Current Price
$0.86
Undervalued Fair Value Overvalued
According to Bulios Fair Price, PTIX is currently undervalued relative to its market price. How does it work?
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Piotroski F-Score Moderate
5/9Valuation
100 /100
Cheap P/E 0.28x
P/B 0.90x
EV/EBITDA N/A
Growth
-
N/A EPS growth N/A
Rev. growth N/A
Book val. growth N/A
Profitability
-
N/A Gross margin N/A
Net margin N/A
FCF margin N/A
Quality
21 /100
Poor ROIC 246.99%
ROA 261.82%
Asset turnover 0.00x
Debt
50 /100
Moderate Debt/Equity 0.00x
Current ratio 0.66x
Int. coverage -2.24x
Stability
29 /100
Unstable Beta 1.07x
EPS volatility 109.45%
Profitable years 0
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about PTIX
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Garo H. Armen
Employees
2
Headquarters
New York
Upcoming events
17 NOV
Earnings
Upcoming earnings report